| Cat.No. | Name | Information |
|---|---|---|
| M7325 | Rimonabant Hydrochloride | Rimonabant hydrochloride is a cannabinoid receptor antagonist, which binds selectively to central cannabinoid receptors (CB1) with high affinity |
| M56148 | TC-C 14G | TC-C 14G (Compd 14g) is a Cannabinoid-1 Receptor (CB1R) inverse agonist, with a Ki of 4 nM and EC50 of 11 nM for HCB1R, respectively. |
| M56147 | CB2R PAM | CB2R PAM is an orally active cannabinoid type-2 receptors (CB2Rs) positive allosteric modulator. |
| M56146 | Nonabine | Nonabine (BRL-4664), a cannabinoid, is a antiemetic agent. |
| M56145 | CB2 modulator 1 | CB2 modulator 1 is a potent CB2 modulator. |
| M56144 | CB2 receptor agonist 2 | CB2 receptor agonist 2 is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor with a Ki of 8.5 nM. |
| M54860 | Vicasinabin | Vicasinabin (RG7774) is the potent agonist of cannabinoid receptor 2 (CB2). |
| M54730 | INV-347 | INV-347 is a CB1R inverse agonist that can be used in studies related to obesity. |
| M54196 | RVD-Hpα TFA | RVD-Hpα TFA is the N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist. RVD-Hpα TFA increases intracellular Ca2+ levels in cells expressing CB1 receptors in vitro. RVD-Hpα TFA also high affinity CB2 positive allosteric modulator (Ki=50 nM). |
| M53236 | Hemopressin(human, mouse) TFA | Hemopressin TFA is a nonapeptide derived from the α1-chain of hemoglobin, is originally isolated from rat brain homogenates. |
| M53235 | Hemopressin(rat) TFA | Hemopressin(rat) TFA is a nonapeptide derived from the α1-chain of hemoglobin, is originally isolated from rat brain homogenates. |
| M53234 | Hemopressin(rat) | Hemopressin(rat) is a nonapeptide derived from the α1-chain of hemoglobin, is originally isolated from rat brain homogenates. |
| M53233 | Pirnabine | Pirnabine is a cannabinoid receptor ligand. |
| M45351 | Surinabant | Surinabant is a selective, high affinity, orally active cannabinoid receptor type 1 CB1R antagonist. |
| M45349 | PF-431499 | PF-431499 is a cannabinoid receptor CB1 antagonist for research related to endocrine and metabolic diseases. |
| M45346 | CXB-029 | CXB-029 is a cannabinoid receptor CB1 antagonist that can be used in studies related to glaucoma and obesity. |
| M45345 | CRB-913 | CRB-913 is a novel, orally active cannabinoid receptor CB1 inverse agonist for research related to endocrine and metabolic diseases. |
| M45344 | CP-741952 | CP-741952 is a cannabinoid receptor CB1 antagonist for research related to endocrine and metabolic diseases. |
| M45343 | BMS-812204 | BMS-812204 is a cannabinoid receptor CB1 antagonist for research related to endocrine and metabolic diseases. |
| M45342 | AZD-2207 | AZD-2207 is a cannabinoid receptor CB1 antagonist and highly lipophilic compound that can be used in studies related to type 2 diabetic disease and obesity. |
| M45341 | Ajulemic acid | Ajulemic acid is a synthetic, orally available Δ9-tetrahydrocannabinol metabolite and cannabinoid receptor agonist with Ki values of 5.7 nM for hCB1 and 56.1 nM for hCB2, and EC50 values of 11.6 nM and 13.4 nM, respectively. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
